EP0804542A4 - Verfahren zur herstellung von verstärkt antigen wirkenden darmbakterien und damit enthaltene impfstoffe - Google Patents

Verfahren zur herstellung von verstärkt antigen wirkenden darmbakterien und damit enthaltene impfstoffe

Info

Publication number
EP0804542A4
EP0804542A4 EP95937449A EP95937449A EP0804542A4 EP 0804542 A4 EP0804542 A4 EP 0804542A4 EP 95937449 A EP95937449 A EP 95937449A EP 95937449 A EP95937449 A EP 95937449A EP 0804542 A4 EP0804542 A4 EP 0804542A4
Authority
EP
European Patent Office
Prior art keywords
intellectory
bacteria
production
reinforced anti
vaccines contained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95937449A
Other languages
English (en)
French (fr)
Other versions
EP0804542A1 (de
Inventor
John L Pace
Richard I Walker
Steven M Frey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emergent Product Development Gaithersburg Inc
Original Assignee
Antex Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/538,545 external-priority patent/US5679564A/en
Application filed by Antex Biologics Inc filed Critical Antex Biologics Inc
Publication of EP0804542A1 publication Critical patent/EP0804542A1/de
Publication of EP0804542A4 publication Critical patent/EP0804542A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045—Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP95937449A 1994-10-05 1995-10-04 Verfahren zur herstellung von verstärkt antigen wirkenden darmbakterien und damit enthaltene impfstoffe Withdrawn EP0804542A4 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US31840994A 1994-10-05 1994-10-05
US318409 1994-10-05
US08/538,545 US5679564A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic campylobacter bacteria and vaccines
US08/538,543 US5681736A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
US538545 1995-10-03
PCT/US1995/013196 WO1996011258A1 (en) 1994-10-05 1995-10-04 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same
US538543 2000-03-30

Publications (2)

Publication Number Publication Date
EP0804542A1 EP0804542A1 (de) 1997-11-05
EP0804542A4 true EP0804542A4 (de) 1998-10-28

Family

ID=27405987

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95937449A Withdrawn EP0804542A4 (de) 1994-10-05 1995-10-04 Verfahren zur herstellung von verstärkt antigen wirkenden darmbakterien und damit enthaltene impfstoffe

Country Status (16)

Country Link
EP (1) EP0804542A4 (de)
JP (1) JP3394047B2 (de)
CN (1) CN1168693A (de)
AU (1) AU704283B2 (de)
BR (1) BR9509276A (de)
CA (1) CA2202027A1 (de)
CZ (1) CZ104397A3 (de)
FI (1) FI971403A7 (de)
HU (1) HUT77876A (de)
IL (1) IL115521A0 (de)
MX (1) MX9702431A (de)
NO (1) NO971519L (de)
NZ (1) NZ295907A (de)
PL (1) PL182700B1 (de)
SG (2) SG73509A1 (de)
WO (1) WO1996011258A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0792347T3 (da) * 1994-10-05 2006-04-03 Emergent Immunosolutions Inc Fremgangsmåder til fremstilling af forbedrede antigene Heliobacter sp. og vacciner omfattende samme
EP2327720A1 (de) * 2003-05-30 2011-06-01 Intercell AG Enterokokken-Antigene
WO2007108903A2 (en) * 2006-03-17 2007-09-27 Cerebus Biologicals, Inc. Campylobacter vaccines and methods of use
US8465754B2 (en) 2007-05-28 2013-06-18 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Bordetella parapertussis whole-cell vaccine composition
CN107513553B (zh) * 2017-09-18 2021-05-18 江南大学 一种筛选具有拮抗空肠弯曲杆菌感染功能的乳酸菌的方法
CN109633151B (zh) * 2018-12-26 2022-03-11 西北农林科技大学 一种肠炎沙门氏菌检测方法、试纸条及应用
WO2020141103A1 (en) 2018-12-31 2020-07-09 Bellevacc As Bacterial vaccine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533492A2 (de) * 1991-09-18 1993-03-24 Amgen Inc. Gallensäure enthaltende Hepatitis-B-Impfstoff-Zusammensetzung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533492A2 (de) * 1991-09-18 1993-03-24 Amgen Inc. Gallensäure enthaltende Hepatitis-B-Impfstoff-Zusammensetzung

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
95TH GENERAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, D.C., USA, MAY 21-25, 1995. ABSTRACTS OF THE GENERAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY 95 (0). 1995. 183 *
DATABASE BIOSIS BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; ROLLINS D M ET AL: "Functional In Vitro Assays for Maximizing Campylobacter Cross-Strain Agglutination Through Optimization of Culture Conditions.", XP002075401 *
POPE L M ET AL: "Increased protein secretion and adherence to HeLa cells by Shigella spp. following growth in the presence of bile salts.", INFECTION AND IMMUNITY, (1995 SEP) 63 (9) 3642-8, XP002075400 *
See also references of WO9611258A1 *

Also Published As

Publication number Publication date
JP3394047B2 (ja) 2003-04-07
EP0804542A1 (de) 1997-11-05
IL115521A0 (en) 1996-06-18
AU3956195A (en) 1996-05-02
FI971403A0 (fi) 1997-04-04
SG73509A1 (en) 2000-06-20
WO1996011258A1 (en) 1996-04-18
NO971519L (no) 1997-05-27
BR9509276A (pt) 1997-11-18
HUT77876A (hu) 1998-09-28
FI971403L (fi) 1997-06-04
PL319580A1 (en) 1997-08-18
PL182700B1 (pl) 2002-02-28
AU704283B2 (en) 1999-04-15
SG73510A1 (en) 2000-06-20
NZ295907A (en) 1999-04-29
FI971403A7 (fi) 1997-06-04
NO971519D0 (no) 1997-04-03
CN1168693A (zh) 1997-12-24
JPH10507347A (ja) 1998-07-21
CA2202027A1 (en) 1996-04-18
MX9702431A (es) 1998-05-31
CZ104397A3 (cs) 1998-06-17

Similar Documents

Publication Publication Date Title
DE69403797D1 (de) Nichtgewebte materialien und methode zur herstellung derselben
EP0783727A4 (de) Mikrostrukturen und verfahren zur herstellung von mikrostrukturen
DE59810636D1 (de) Verfahren zur herstellung von glufosinate und zwischenprodukte dafür
DE69535674D1 (de) Verfahren zur herstellung von l-valin und l-leucin
EP0655777A3 (de) Varaktor und Verfahren zur Herstellung.
EP0863762A4 (de) Verfahren zur herstellung und verwendung von flüssigformulierungen mit plasmaproteinen
DE69300528D1 (de) Mikropumpe und Verfahren zur Herstellung.
DE59702349D1 (de) Verfahren zur herstellung von aminen und aminonitrilen
DE59504187D1 (de) Verfahren zur Herstellung von ultrareinem Bisphenol-A und dessen Verwendung
DE69425748D1 (de) Transistoren und verfahren zur herstellung
DE69531196D1 (de) Vorrichtung und verfahren zur herstellung von transmissionshologrammen
DE59703443D1 (de) Verfahren zur herstellung von aminen und aminonitrilen
DE59002992D1 (de) Hotelkanne und Verfahren zur Herstellung derselben.
DE69613964D1 (de) Verfahren zur herstellung von pentafluoroethan und tetrafluorochloroethan
DE69321848D1 (de) Verfahren zur herstellung von 1,1,1,2,3,3-hexafluorpropan und von tetrafluorchlorpropen
DE59606485D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
EP0804542A4 (de) Verfahren zur herstellung von verstärkt antigen wirkenden darmbakterien und damit enthaltene impfstoffe
DE69902714D1 (de) Verfahren zur Herstellung von Naturkautschuk und damit erhaltener Naturkautschuk
DE59606489D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE59101473D1 (de) Verfahren zur Herstellung von N-aryl-substituierten 2-Aminoalkyl-2-hydroxy-alkylaminen und N-arylsubstituierten Piperazinen.
DE69313297D1 (de) Benzofuranone, benzodifurantrione und verfahren zur herstellung von benzodifurandionen
DE59106553D1 (de) Verfahren zur herstellung von chlorfluornitrobenzolen und difluornitrobenzolen.
ATE370751T1 (de) Verfahren zur herstellung von dekontaminierten und sterilisierten korken
EP0726715A4 (de) Psyllium enthaltendes stabforzeiges konfekt; verfahren zur herstellung desselben und verwendung desselben
DE68906986D1 (de) Verfahren zur herstellung von chf20chfcf3 und chf20chclcf3 und dabei verwendete zwischenverbindungen.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970417

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: SI PAYMENT 970417

A4 Supplementary search report drawn up and despatched

Effective date: 19980914

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20011212

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040101